CIK: 0001119376 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 8, 2023
Total Value ($000): $29 (50.2% shares, 49.8% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Coherus Biosciences Inc | 18,000,000 | $11 | 37.4% | $0.65 | — | Bond | 19249HAB9 |
| PHYS | Sprott Physical Gold Trust | 264,500 | $4 | 12.8% | $5.93 | — | ETF | 85207H104 |
| — | Coherus Biosciences Inc | 3,434,000 | $4 | 12.4% | $0.85 | — | Bond | 30050BAD3 |
| AAAU | Goldman Sachs Physical Gold | 184,254 | $3 | 11.4% | $17.99 | — | Common | 38150K103 |
| META | Humana Inc | 8,000 | $2 | 8.1% | $138.02 | +116.8% | Common | 30303M102 |
| HUM | Humana Inc | 3,400 | $2 | 5.6% | $488.15 | -6.5% | Common | 444859102 |
| CCI | Crown Castle Intl | 12,000 | $1 | 3.7% | $123.24 | -26.7% | Common | 22822V101 |
| IAU | Johnson & Johnson Inc | 28,000 | $1 | 3.3% | $33.71 | — | Common | 464285204 |
| GOOG | Alphabet Inc Class C | 5,500 | $1 | 2.5% | $110.17 | +17.1% | Common | 02079K107 |
| JNJ | Matinas Biopharma Holdings Inc | 2,000 | $0 | 1.1% | $127.01 | +20.7% | Common | 478160104 |
| GD | General Dynamics Corp | 1,200 | $0 | 0.9% | $147.01 | +43.6% | Common | 369550108 |
| CHRS | Coherus Biosciences Inc | 50,000 | $0 | 0.6% | $5.90 | -21.7% | Common | 19249H103 |